loading
Pharming Group N V Adr stock is traded at $13.70, with a volume of 19,253. It is up +8.21% in the last 24 hours and up +39.80% over the past month. Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
See More
Previous Close:
$12.66
Open:
$13.38
24h Volume:
19,253
Relative Volume:
3.06
Market Cap:
$938.65M
Revenue:
$277.56M
Net Income/Loss:
$-13.33M
P/E Ratio:
-72.10
EPS:
-0.19
Net Cash Flow:
$-6.54M
1W Performance:
+17.60%
1M Performance:
+39.80%
6M Performance:
+54.63%
1Y Performance:
+72.33%
1-Day Range:
Value
$13.28
$13.83
1-Week Range:
Value
$11.98
$13.83
52-Week Range:
Value
$6.73
$17.08

Pharming Group N V Adr Stock (PHAR) Company Profile

Name
Name
Pharming Group N V Adr
Name
Phone
-
Name
Address
-
Name
Employee
404
Name
Twitter
Name
Next Earnings Date
2024-10-24
Name
Latest SEC Filings
Name
PHAR's Discussions on Twitter

Compare PHAR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PHAR
Pharming Group N V Adr
13.70 848.90M 277.56M -13.33M -6.54M -0.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-09-24 Initiated Jefferies Buy

Pharming Group N V Adr Stock (PHAR) Latest News

pulisher
Aug 06, 2025

Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet - Yahoo Finance

Aug 06, 2025
pulisher
Aug 02, 2025

Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume on Earnings Beat - Defense World

Aug 02, 2025
pulisher
Aug 01, 2025

New Strong Buy Stocks for August 1st - TradingView

Aug 01, 2025
pulisher
Aug 01, 2025

Pharming Group (NASDAQ:PHAR) Shares Gap Up After Earnings Beat - Defense World

Aug 01, 2025
pulisher
Jul 25, 2025

Best Momentum Stocks to Buy for July 25th - TradingView

Jul 25, 2025
pulisher
Jul 25, 2025

New Strong Buy Stocks for July 25th - TradingView

Jul 25, 2025
pulisher
Jul 19, 2025

New Strong Buy Stocks for July 17th - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

Best Momentum Stocks to Buy for July 17th - NewsBreak: Local News & Alerts

Jul 18, 2025
pulisher
May 31, 2025

PHAR stock hits 52-week high at $11.14 amid robust growth By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 31, 2025

PHAR stock hits 52-week high at $11.14 amid robust growth - Investing.com India

May 31, 2025
pulisher
May 03, 2025

Pharming To Attend The H.C. Wainwright BioConnect Investor Conference 2023 - Barchart.com

May 03, 2025
pulisher
Apr 25, 2025

SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock? - Nasdaq

Apr 25, 2025
pulisher
Apr 24, 2025

META_TITLE_SECTORS - Yahoo Finance

Apr 24, 2025
pulisher
Mar 14, 2025

H.C. Wainwright maintains Buy on Pharming with $37 price target - Investing.com

Mar 14, 2025
pulisher
Feb 28, 2025

Pharming Group to participate in March investor conference - GlobeNewswire Inc.

Feb 28, 2025
pulisher
Dec 21, 2024

Pharming Group N.V. (AMS:PHARM) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St

Dec 21, 2024
pulisher
Dec 19, 2024

Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com

Dec 19, 2024
pulisher
Oct 03, 2024

Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance

Oct 03, 2024
pulisher
Mar 03, 2024

RGC Stock Quote Price and Forecast - CNN

Mar 03, 2024
pulisher
Jan 18, 2024

symbol__ Stock Quote Price and Forecast - CNN

Jan 18, 2024
pulisher
Mar 14, 2023

Why Earnings Season Could Be Great for Pharming Group (PHAR) - Yahoo Finance

Mar 14, 2023
pulisher
Nov 08, 2022

Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Nov 08, 2022
pulisher
Oct 18, 2022

Are Medical Stocks Lagging Lantheus (LNTH) This Year? - Nasdaq

Oct 18, 2022
pulisher
Jan 19, 2021

Pharming Group (PHAR) Earnings Date and Reports 2025 - MarketBeat

Jan 19, 2021
pulisher
Jan 19, 2021

PHAR News Today | Why did Pharming Group stock go up today? - MarketBeat

Jan 19, 2021
pulisher
Jan 19, 2021

Pharming Group (PHAR) Stock Price, News & Analysis - MarketBeat

Jan 19, 2021
pulisher
Dec 26, 2020

Pharming Group (PHAR) - Zacks Investment Research

Dec 26, 2020
pulisher
Jul 25, 2017

PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView

Jul 25, 2017

Pharming Group N V Adr Stock (PHAR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):